Metabolism of pancreatic cancer: paving the way to better anticancer strategies

Pancreatic cancer is currently one of the most lethal diseases. In recent years, increasing evidence has shown that reprogrammed metabolism may play a critical role in the carcinogenesis, progression, treatment and prognosis of pancreatic cancer. Affected by internal or external factors, pancreatic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular cancer Jg. 19; H. 1; S. 50 - 19
Hauptverfasser:	Qin, Cheng, Yang, Gang, Yang, Jinshou, Ren, Bo, Wang, Huanyu, Chen, Guangyu, Zhao, Fangyu, You, Lei, Wang, Weibin, Zhao, Yupei
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 02.03.2020 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	Amino acids Animals Antineoplastic Agents - therapeutic use Biomarkers, Tumor - metabolism Biomedical and Life Sciences Biomedicine Biosynthesis Cancer cells Cancer Research Cancer therapies Cancer treatment Carcinogenesis Chemoresistance Chemotherapy Clinical trials Dehydrogenases Development and progression Diseases Drug therapy Energy Metabolism Enzymes Gemcitabine Gene expression Glucose Health aspects Humans Immunosuppression Immunotherapy Kinases Lipids Medical prognosis Metabolic Networks and Pathways - drug effects Metabolism Methods Mutation Oncology Pancreatic cancer Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - pathology Patients Physiological aspects Radiation therapy Radioresistance Radiotherapy Review Tumors United States > US Immunosuppression Gemcitabine Pancreatic cancer Chemoresistance Clinical trials Radioresistance Metabolism
ISSN:	1476-4598, 1476-4598
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!